Comparative proteomic analysis of the function and network mechanisms of MASPIN in human lung cells

Experimental and Therapeutic Medicine

Volumn 3, Issue 3, 2012, Pages 470-474

  Liu, Yao ^a   Geng, Yi ^a   Li, Kuanzhi ^a   Wang, Fang ^a   Zhou, Haiping ^a   Wang, Wanhu ^a   Hou, Jie ^a   Liu, Wenchao ^b  

^a Baoji Center Hospital of Shanxi Province   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lung cancer; MASPIN; Two dimensional gel electrophoresis

Indexed keywords

MASPIN;

ARTICLE; CANCER CELL; CT62 GENE; DRUG MECHANISM; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LDOC1 GENE; LUNG CARCINOMA; NEED9 GENE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCAI GENE; SDCCAG3 GENE; SDCCAG8 GENE; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84862939291     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.427     Document Type: Article

References (27)

1. Zou Z, Gao C, Nagaich AK, et al: p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275: 6051-6054, 2000.
2. Shi HY, Zhang W, Liang R, et al: Modeling human breast cancer metastasis in mice: maspin as a paradigm. Histol Histopathol 18: 01-206, 2003.
3. Abraham S, Zhang W, Greenberg N and Zhang M: Maspin functions as tumor suppressor by increasing cell adhesion to extra-cellular matrix in prostate tumor cells. J Urol 169: 1157-1161, 2003.
4. Machtens S, Serth J, Bokemeyer C, et al: Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 95: 337-342, 2001.
5. Schaefer JS and Zhang M: Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med 3: 653-658, 2003.
6. Cher ML, Biliran HR Jr, Bhagat S, et al: Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci USA 100: 7847-7852, 2003.
7. Dokras A, Coffin J, Field L, et al. Epigenetic regulation of maspin expression in the human placenta. Mol Hum Reprod. 12: 611-617, 2006.
8. Brandt DT, Baarlink C, Kitzing TM, et al: SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin. Nat Cell Biol 11: 557-568, 2009.
9. Neznanov N, Neznanova L, Angres B and Gudkov AV: Serologically defined colon cancer antigen 3 is necessary for the presentation of TNF receptor 1 on cell surface. DNA Cell Biol24: 777-785, 2005.
10. Nagasaki K, Schem C, von Kaisenberg C, et al: Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int J Cancer 105: 454-458, 2003.
11. Cicek M, Fukuyama R, Welch DR, Sizemore N and Casey G: Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res 65: 3586-3595, 2005.
12. Park S, Lim Y, Lee D, et al: Identification and characterization of a novel cancer/testis antigen gene CAGE-1. Biochim Biophys Acta 1625: 173-182, 2003.
13. Kim M, Gans JD, Nogueira C, et al: Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125: 1269-1281, 2006.
14. Merrill RA, See AW, Wertheim ML and Clagett-Dame M: Crk-associated substrate (Cas) family member, NEDD9, is regulated in human neuroblastoma cells and in the embryonic hindbrain by all-trans retinoic acid. Dev Dyn 231: 564-575, 2004.
15. Bonnefoy A, Daenens K, Feys HB, et al: Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood 107: 955-964, 2006.
16. Lorsbach RB, Moore J, Ang SO, Sun W, Lenny N and DowningJR: Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. Blood 103: 2522-2529, 2004.
17. Hirai H, Samokhvalov IM, Fujimoto T, Nishikawa S, Imanishi J and Nishikawa S: Involvement of Runx1 in the down-regulation of fetal liver kinase-1 expression during transition of endothelial cells to hematopoietic cells. Blood 106: 1948-1955, 2005.
18. Schlaepfer DD, Hauck CR and Sieg DJ: Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71: 435-478, 1999.
19. Bernard-Trifilo JA, Lim ST, Hou S, Schlaepfer DD and Ilic D: Analyzing FAK and Pyk2 in early integrin signaling events. Curr Protoc Cell Biol Chapter 14: Unit 14.7, 2006.
20. Maass N, Teffner M, Rosel F, et al: Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 195: 321-326, 2001.
21. Umekita Y, Ohi Y, Sagara Y and Yoshida H: Expression of maspin predicts poor prognosis in breast-cancer patients. Int J Cancer 100: 452-455, 2002.
22. Futscher BW, Oshiro MM, Wozniak RJ, et al: Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 31: 175-179, 2002.
23. Maass N, Biallek M, Rosel F, et al: Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 297: 125-128, 2002.
24. Bass R, Fernandez AM and Ellis V: Maspin inhibits cell migration in the absence of protease inhibitory activity. J Biol Chem 277: 46845-46848, 2002.
25. Biliran H Jr and Sheng S: Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 61: 8676-8682, 2001.
26. Jiang N, Meng Y, Zhang S, Mensah-Osman E and Sheng S: Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21: 4089-4098, 2002.
27. Shi HY, Liang R, Templeton NS and Zhang M: Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model. Mol Ther 5: 755-761, 2002.